RemedyBio is now supported through funding from the Irish Research Council to investigate patient stratification and therapeutic development using mass scale single cell analysis, in partnership with Dublin City University. This adds to our existing programme, also supported by IRC, in patient-guided immunological studies for the development of cancer therapies.
